首页 | 本学科首页   官方微博 | 高级检索  
检索        

TCRP联合亮丙瑞林用于子宫内膜息肉患者对性激素水平及术后复发的影响
引用本文:王敏侠,刘杨,于汉凤.TCRP联合亮丙瑞林用于子宫内膜息肉患者对性激素水平及术后复发的影响[J].国际医药卫生导报,2022,28(3):399-402.
作者姓名:王敏侠  刘杨  于汉凤
作者单位:1蒙阴县人民医院妇产科,临沂 276200; 2蒙阴县中医院妇产科,临沂 276200
摘    要:目的:研究宫腔镜子宫内膜息肉电切术(TCRP)联合亮丙瑞林治疗子宫内膜息肉对患者性激素水平及术后复发的影响。方法:收集2015年1月至2020年8月在蒙阴县人民医院治疗的280例子宫内膜息肉患者的临床资料,按治疗方式分为对照组(120例)和观察组(160例)。对照组患者年龄26~55(40.12±4.18)岁,病程4~...

关 键 词:宫腔镜子宫内膜息肉电切术  亮丙瑞林  子宫内膜息肉  性激素  复发
收稿时间:2021-09-06

Effect of TCRP combined with leuprorelin on levels of sex hormones and postoperative recurrence in patients with endometrial polyps
Wang Minxia,Liu Yang,Yu Hanfeng.Effect of TCRP combined with leuprorelin on levels of sex hormones and postoperative recurrence in patients with endometrial polyps[J].International Medicine & Health Guidance News,2022,28(3):399-402.
Authors:Wang Minxia  Liu Yang  Yu Hanfeng
Institution:1 Department of Gynecology and Obstetrics, Mengyin County People' s Hospital, Linyi 276200, China;  2 Department of Gynecology and Obstetrics, Mengyin County Hospital of Traditional Chinese Medicine, Linyi 276200, China
Abstract:Objective To study the effect of transcervical resection of polyps (TCRP) combined with leuprorelin on the levels of sex hormones and postoperative recurrence in patients with endometrial polyps. Methods The clinical data of 280 patients with endometrial polyps who were treated at Mengyin County People' s Hospital between January 2015 and August 2020 were collected. The patients were divided into a control group (120 cases) and an observation group (160 cases) according to the treatment methods. The control group were 26-55 (40.12±4.18) years old, with a disease course of 4-11 (6.02±1.17) months. The observation group were 28-55 (39.63±4.21) years old, with a disease course of 3-10 (5.76±1.20) months. The control group were treated by TCRP, and the observation group by TCRP and leuprorelin. The levels of sex hormones and postoperative recurrence were compared between the two groups. The enumeration data were compared between these two groups by χ2 test, and the measurement data by independent-sample t test. Results The total clinical effective rate was 95.00% (152/160) in the observation group, and was 88.33% (106/120) in the control group, with a statistical difference (χ2=4.210, P=0.040). Before the treatment, there was no statistical difference in the endometrial thickness between the two groups (P>0.05). One, three, and six months after the treatment, the endometrial thicknesses of the two groups declined, and those in the observation group were lower than those in the control group (all P<0.001). There were no statistical differences in the levels of estradiol (E2), progesterone (P), and follicle-stimulating hormone (FSH) between the two groups before the treatment (all P>0.05); after treatment, the levels of the above indicators of the two groups declined, and those in the observation group were significantly lower than those in the control group (all P<0.001). After the treatment, the recurrence rate and the incidences of complications were significantly lower and more patients had normal menstruation in the observation group than in the control group (all P<0.05). Conclusion TCRP combined with leuprorelin for patients with endometrial polyps has a significant efficacy and good recovery of postoperative hormones, and can effectively reduce the recurrence rate and complications and maintain the patients' menstruation normal after surgery.
Keywords:Transcervical resection of polyps  Leuprorelin  Endometrial polyps  Sex hormones  Recurrence
本文献已被 万方数据 等数据库收录!
点击此处可从《国际医药卫生导报》浏览原始摘要信息
点击此处可从《国际医药卫生导报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号